This review will discuss issues arising along with the expanding use of hypomethylating treatment (HMT) in the management of acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS).

Voso, M.t., Lo Coco, F., & Fianchi, L. (2015). Epigenetic therapy of myelodysplastic syndromes and acute myeloid leukemia. CURRENT OPINION IN ONCOLOGY, 27(6), 532-539 [10.1097/CCO.0000000000000231].

Epigenetic therapy of myelodysplastic syndromes and acute myeloid leukemia

VOSO, MARIA TERESA;LO COCO, FRANCESCO;
2015-11

Abstract

This review will discuss issues arising along with the expanding use of hypomethylating treatment (HMT) in the management of acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS).
In corso di stampa
Rilevanza internazionale
Editoriale
Esperti anonimi
Settore MED/15 - Malattie del Sangue
English
Voso, M.t., Lo Coco, F., & Fianchi, L. (2015). Epigenetic therapy of myelodysplastic syndromes and acute myeloid leukemia. CURRENT OPINION IN ONCOLOGY, 27(6), 532-539 [10.1097/CCO.0000000000000231].
Voso, Mt; LO COCO, F; Fianchi, L
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2108/134519
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 17
social impact